Non–small cell lung cancer (NSCLC) is the second most common cancer in men and women, and the number of survivors needing routine surveillance is expected to increase by >20% in the next decade. Existing surveillance guidelines are largely based on limited quality data and expert opinion. They do not account for individual variations in risk of recurrence, survival, or patient preference that are critical for patient-centered care. The goal of this proposal is to develop new knowledge on NSCLC surveillance to improve its effectiveness.
